BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2021 9:22:17 AM | Browse: 197 | Download: 342
 |
Received |
|
2021-01-20 02:50 |
|
Peer-Review Started |
|
2021-01-20 02:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-23 07:02 |
|
Revised |
|
2021-03-01 12:31 |
|
Second Decision |
|
2021-04-08 09:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-13 14:40 |
|
Articles in Press |
|
2021-04-13 14:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-26 09:47 |
|
Typeset the Manuscript |
|
2021-06-07 07:08 |
|
Publish the Manuscript Online |
|
2021-06-11 09:22 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ratchapong Laiwatthanapaisan and Apichet Sirinawasatien |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Apichet Sirinawasatien, MD, Doctor, Department of Internal Medicine, Division of Gastroenterology, Rajavithi Hospital, College of Medicine, Rangsit University, 2 Phayathai Road, Rajathewi, Bangkok 10400, Thailand, Bangkok 10400, Thailand. sui_apichet@hotmail.com |
| Key Words |
Viral hepatitis C; Human immunodeficiency virus, Liver fibrosis; Cirrhosis; Hepatocellular carcinoma; Direct-acting antiviral agents; Antiretroviral therapy |
| Core Tip |
Hepatitis C virus (HCV) coinfection is a major cause of liver related disease among human immunodeficiency virus (HIV) patients, and it has higher rates of morbidity and mortality compared with HCV-monoinfected patients. Direct-acting antiviral agents (DAA) treatment has shown good efficacy in HCV/HIV-coinfected patients and has been found to achieve sustained virologic response (SVR) rates similar to those of HCV-monoinfected patients. The appropriate selection of DAA regiment is of crucial importance, however, and drug interaction with antiretroviral therapy should be taken into account to avoid adverse outcomes and lower rates of SVR. |
| Publish Date |
2021-06-11 09:22 |
| Citation |
Laiwatthanapaisan R, Sirinawasatien A. Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults. World J Clin Cases 2021; 9(18): 4491-4499 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i18/4491.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i18.4491 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
